These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 18306426

  • 1. Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori.
    Morihara F, Hifumi E, Yamada M, Nishizono A, Uda T.
    Biotechnol Bioeng; 2008 Jul 01; 100(4):634-43. PubMed ID: 18306426
    [Abstract] [Full Text] [Related]

  • 2. Effects of vaccination by a recombinant antigen ureB138 (a segment of the beta-subunit of urease) against Helicobacter pylori infection.
    Morihara F, Fujii R, Hifumi E, Nishizono A, Uda T.
    J Med Microbiol; 2007 Jun 01; 56(Pt 6):847-853. PubMed ID: 17510273
    [Abstract] [Full Text] [Related]

  • 3. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C, Roussel Y, Harris AG, Wren BW, Morrow JW, Bajaj-Elliott M.
    Helicobacter; 2006 Apr 01; 11(2):113-22. PubMed ID: 16579841
    [Abstract] [Full Text] [Related]

  • 4. Recombinant antigen from Helicobacter pylori urease as vaccine against H. pylori-associated disease.
    Fujii R, Morihara F, Fukushima K, Oku T, Hifumi E, Uda T.
    Biotechnol Bioeng; 2004 Jun 30; 86(7):737-46. PubMed ID: 15162449
    [Abstract] [Full Text] [Related]

  • 5. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K, Kato S, Tsukui T, Sakamoto C.
    J Gastroenterol Hepatol; 2006 Jan 30; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [Abstract] [Full Text] [Related]

  • 6. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
    Corthésy B, Boris S, Isler P, Grangette C, Mercenier A.
    J Infect Dis; 2005 Oct 15; 192(8):1441-9. PubMed ID: 16170763
    [Abstract] [Full Text] [Related]

  • 7. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B, Eck M, Greiner A, Lührs H, Vollmers HP, Müller-Hermelink HK.
    Virchows Arch; 2002 Aug 15; 441(2):143-7. PubMed ID: 12189503
    [Abstract] [Full Text] [Related]

  • 8. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
    Nomura S, Suzuki H, Masaoka T, Kurabayashi K, Ishii H, Kitajima M, Nomoto K, Hibi T.
    Helicobacter; 2005 Feb 15; 10(1):43-52. PubMed ID: 15691314
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A.
    Helicobacter; 2009 Oct 15; 14(5):135-43. PubMed ID: 19751439
    [Abstract] [Full Text] [Related]

  • 10. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.
    Lucas B, Bumann D, Walduck A, Koesling J, Develioglu L, Meyer TF, Aebischer T.
    Infect Immun; 2001 Mar 15; 69(3):1714-21. PubMed ID: 11179348
    [Abstract] [Full Text] [Related]

  • 11. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X, Hu J, Zhang X, Fan D.
    Chin Med J (Engl); 2002 Oct 15; 115(10):1513-6. PubMed ID: 12490099
    [Abstract] [Full Text] [Related]

  • 12. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori.
    Zhang H, Liu M, Li Y, Zhao Y, He H, Yang G, Zheng C.
    Protein Expr Purif; 2010 Feb 15; 69(2):127-31. PubMed ID: 19651219
    [Abstract] [Full Text] [Related]

  • 13. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W, Wu W, Xu X.
    Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305
    [Abstract] [Full Text] [Related]

  • 14. A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice.
    Hatzifoti C, Bajaj-Elliott M, Dorrell N, Anyim M, Prentice MB, Nye KE, Wren B, Morrow WJ.
    Vaccine; 2004 Jun 30; 22(20):2651-9. PubMed ID: 15193391
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
    Taylor JM, Ziman ME, Huff JL, Moroski NM, Vajdy M, Solnick JV.
    Vaccine; 2006 Jun 05; 24(23):4987-94. PubMed ID: 16621176
    [Abstract] [Full Text] [Related]

  • 16. Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit.
    Kubota E, Joh T, Tanida S, Sasaki M, Kataoka H, Watanabe K, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Yamada T, Mori Y, Fujita F, Shimura T, Ohara H, Isaka M, Yasuda Y, Itoh M.
    Helicobacter; 2005 Aug 05; 10(4):345-52. PubMed ID: 16104951
    [Abstract] [Full Text] [Related]

  • 17. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T, Liu WZ, Gao F, Shi GY, Xiao SD.
    Helicobacter; 2005 Feb 05; 10(1):71-9. PubMed ID: 15691317
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of immune prophylaxis of recombinant urease subunit of Helicobacter pylori].
    Shi L, Wang J, Chen Y.
    Zhonghua Yi Xue Za Zhi; 2000 Nov 05; 80(11):811-5. PubMed ID: 11218872
    [Abstract] [Full Text] [Related]

  • 19. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L, Breslin MB, Correa H, Bégué RE.
    Helicobacter; 2006 Dec 05; 11(6):517-22. PubMed ID: 17083372
    [Abstract] [Full Text] [Related]

  • 20. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice].
    Lin HJ, Yang Q, Li J, Liu Y, Wang QY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar 05; 28(3):436-7. PubMed ID: 18359706
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.